Immunology. The origin of TH2 responses.
Dynavax Technologies Corporation, 2929 Seventh Street, Suite 100, Berkeley, CA 94710, USA. RCoffman@dynavax.com
Robert L
RL
Coffman
D056704:Adaptive Immunity; D000485:Allergens / Q000276:immunology*; D000818:Animals; D000947:Antigens, Helminth / Q000276:immunology; D049109:Cell Proliferation; D006373:Helminthiasis / Q000276:immunology*; D007113:Immunity, Innate; D018793:Interleukin-13 / Q000276:immunology / Q000378:metabolism; D000067596:Interleukin-33; D015847:Interleukin-4 / Q000276:immunology / Q000378:metabolism; D007378:Interleukins / Q000008:administration & dosage / Q000276:immunology*; D008221:Lymphoid Tissue / Q000276:immunology; D051379:Mice; D054504:Precursor Cells, T-Lymphoid / Q000166:cytology / Q000276:immunology* / Q000378:metabolism; D006377:T-Lymphocytes, Helper-Inducer / Q000166:cytology / Q000276:immunology* / Q000378:metabolism; D018418:Th2 Cells / Q000276:immunology*
D000485:Allergens; D000947:Antigens, Helminth; C506535:Il33 protein, mouse; D018793:Interleukin-13; D000067596:Interleukin-33; D007378:Interleukins; C442281:Mydgf protein, mouse; D015847:Interleukin-4